Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 6/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.49 |
| ▸ | CASP1 | P29466 | 1/20 | 0.49 |
| ▸ | CASP7 | P55210 | 1/20 | 0.49 |
| ▸ | SELL | P14151 | 1/20 | 0.47 |
| ▸ | SELP | P16109 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 3/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.40 |
| ▸ | LDHA | P00338 | 1/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | ALB | P02768 | 1/20 | 0.38 |
| ▸ | MMP2 | P08253 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | MPL | P40238 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrazine SCHEMBL9314972 | 0.96 | CYP2D6 (0.53) | CYP2D6HSD17B10ALDH1A1TDP1CASP1 | |
| SCHEMBL6292102 | 0.86 | SELL (0.54) | CYP2D6HSD17B10ALDH1A1TDP1CASP1 | |
| SCHEMBL27262586 | 0.84 | SELL (0.57) | CYP2D6HSD17B10ALDH1A1TDP1CASP1 | |
| SCHEMBL27485805 | 0.84 | SELL (0.52) | CYP2D6HSD17B10ALDH1A1TDP1CASP1 | |
| SCHEMBL27653670 | 0.84 | SELL (0.52) | CYP2D6HSD17B10ALDH1A1TDP1CASP1 | |
| Water SCHEMBL27471406 | 0.82 | SELL (0.50) | CYP2D6HSD17B10ALDH1A1TDP1CASP1 | |
| SCHEMBL27653713 | 0.82 | SELL (0.55) | CYP2D6HSD17B10ALDH1A1TDP1CASP1 | |
| SCHEMBL27877119 | 0.81 | CYP2D6 (0.49) | CYP2D6HSD17B10ALDH1A1TDP1CASP1 | |
| SCHEMBL27827651 | 0.81 | CYP2D6 (0.49) | CYP2D6HSD17B10ALDH1A1TDP1CASP1 | |
| SCHEMBL28018875 | 0.81 | CYP2D6 (0.49) | CYP2D6HSD17B10ALDH1A1TDP1CASP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260102523-A1 | PHARMACEUTICAL COMPOSITION COMPRISING TETROFOSMIN AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | JUBILANT DRAXIMAGE INC (CA) | 2026-04-16 | — | — | US | claimed |
| US-12440583-B2 | Pharmaceutical composition comprising tetrofosmin and pharmaceutically acceptable salts thereof | JUBILANT DRAXIMAGE, INC. (CA) | 2025-10-14 | — | — | US | claimed |
| EP-3592735-B1 | AN IMPROVED PROCESS FOR THE PREPARATION OF TETROFOSMIN OR ACID ADDITION SALT THEREOF | JUBILANT GENERICS LTD FORMERLY A DIVISION OF JUBILANT LIFE SCIENCES LTD (IN) | 2024-03-20 | — | — | EP | claimed |
| US-20240050598-A1 | PHARMACEUTICAL COMPOSITION COMPRISING TETROFOSMIN AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | JUBILANT DRAXIMAGE INC. (CA) | 2024-02-15 | — | — | US | claimed |
| US-11857647-B2 | Pharmaceutical composition comprising tetrofosmin and pharmaceutically acceptable salts thereof | JUBILANT DRAXIMAGE, INC. | 2024-01-02 | — | — | US | claimed |
| EP-1085984-B1 | I INKJET RECEPTOR MEDIA AND COATING SOLUTIONS THEREFOR | MINNESOTA MINING & MFG (US) | 2005-12-28 | — | — | EP | claimed |
| US-6383612-B1 | PIGMENT METAL SALT COATING IMPREGNATED INTO POROUS MEMBRANE; AROMATIC OR ALIPHATIC DRYING AGENT WITH SULFONIC, CARBOXYLIC, PHENOLIC, AND/OR HYDROXYL FUNCTIONAL GROUPS; WATERPROOFING, COLORFASTNESS, NONSMEARING | 3M INNOVATIVE PROPERTIES COMPANY | 2002-05-07 | — | — | US | claimed |
| EP-1085984-A1 | INK-DRYING AGENTS FOR INKJET RECEPTOR MEDIA | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 2001-03-28 | — | — | EP | claimed |
| WO-1999065702-A1 | INK-DRYING AGENTS FOR INKJET RECEPTOR MEDIA | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1999-12-23 | — | — | WO | claimed |
| US-20260102523-A1 | PHARMACEUTICAL COMPOSITION COMPRISING TETROFOSMIN AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | JUBILANT DRAXIMAGE INC (CA) | 2026-04-16 | — | — | US | disclosed |
| US-12440583-B2 | Pharmaceutical composition comprising tetrofosmin and pharmaceutically acceptable salts thereof | JUBILANT DRAXIMAGE, INC. (CA) | 2025-10-14 | — | — | US | disclosed |
| US-20250299889-A1 | SOLID ELECTROLYTIC CAPACITOR ELEMENT AND SOLID ELECTROLYTIC CAPACITOR | PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) | 2025-09-25 | — | — | US | disclosed |
| US-20250104928-A1 | ELECTROLYTIC CAPACITOR AND METHOD OF MANUFACTURING SAME | PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) | 2025-03-27 | — | — | US | disclosed |
| US-12131872-B2 | Electrolytic capacitor and method for producing same | PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) | 2024-10-29 | — | — | US | disclosed |
| US-20040213928-A1 | oriented film having at least one microfibrillated surface comprising polymeric microflakes; can receive jettable materials; good ink receptive properties particularly for solvent based inks | 3M INNOVATIVE PROPERTIES COMPANY | 2004-10-28 | — | — | US | disclosed |
| US-6753080-B1 | Receptor medium having a microfibrillated surface | 3M INNOVATIVE PROPERTIES COMPANY | 2004-06-22 | — | — | US | disclosed |
| WO-2003064166-A1 | RECEPTOR MEDIUM HAVING A MICROFIBRILLATED SURFACE | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2003-08-07 | — | — | WO | disclosed |
| US-6383612-B1 | PIGMENT METAL SALT COATING IMPREGNATED INTO POROUS MEMBRANE; AROMATIC OR ALIPHATIC DRYING AGENT WITH SULFONIC, CARBOXYLIC, PHENOLIC, AND/OR HYDROXYL FUNCTIONAL GROUPS; WATERPROOFING, COLORFASTNESS, NONSMEARING | 3M INNOVATIVE PROPERTIES COMPANY | 2002-05-07 | — | — | US | disclosed |
| EP-1085984-A1 | INK-DRYING AGENTS FOR INKJET RECEPTOR MEDIA | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 2001-03-28 | — | — | EP | disclosed |
| WO-1999065702-A1 | INK-DRYING AGENTS FOR INKJET RECEPTOR MEDIA | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1999-12-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11857647-B2 | Pharmaceutical composition comprising tetrofosmin and pharmaceutically acceptable salts thereof | TREH, TYMP, PRCP | CYP2D6 2986/4885HSD17B10 4728/4885ALDH1A1 4783/4885 |
| US-20260102523-A1 | PHARMACEUTICAL COMPOSITION COMPRISING TETROFOSMIN AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | TREH, CD68, THPO | CYP2D6 1339/4885HSD17B10 4328/4885ALDH1A1 4433/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.